First Ebola Case Diagnosed in the U.S.

Dallas hospital is treating traveler from Liberia

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Federal officials today announced the first case of Ebola diagnosed in the U.S. The male patient was admitted to Texas Health Presbyterian Hospital Dallas and placed in strict isolation on September 28 after flying from Liberia to visit family in north Texas. The patient left Liberia on September 19, arrived in the U.S. on September 20 and started showing signs of illness on Sept. 24. Because Ebola can be transmitted only after a person becomes sick, health authorities said, the man could not have infected nearby passengers.  The individual did not appear to have been in west Africa providing Ebola care.
 
“He undoubtedly had close contact with someone who was sick with Ebola or died from it,” Tom Frieden, the director of the Centers for Disease Control and Prevention said in a press conference this evening. The patient is being cared for in intensive care and any individuals who had potential exposure to him after he began showing symptoms will be contacted and monitored for 21 days. The disease typically has an incubation period of 8 to 10 days.
 
The case comes six months after the World Health Organization first formally published notification of the outbreak in Guinea.  The disease, spread solely by contact with the bodily fluids of symptomatic Ebola patients, has already caused more than 3,000 Ebola deaths in west Africa and rippled from Guinea to Liberia, Nigeria, Senegal and Sierra Leone. Nigeria and Senegal are no longer reporting any new cases, however, suggesting the countries have controlled the outbreak there. Despite some speculation published in the media, the disease is not spread by air and is unlikely to do so as Scientific Americanreported on September 16.
 
For months, the U.S. Centers for Disease Control and Prevention has maintained that unlike the health systems in west Africa, the robust health infrastructure in the U.S. would prevent Ebola from readily spreading if the virus was detected in the country. Healthcare workers who became ill with Ebola while caring for patients in west Africa and transferred to U.S. hospitals recovered without infecting other individuals.
 
Frieden again today reiterated that isolation capabilities at U.S. hospitals, healthcare workers ability to track people who may have been exposed to the ill patient and strong health communication which can alert people about how best to protect themselves, will keep this case from blossoming into a large-scale outbreak. Indeed, the CDC director reminded reporters that a woman who had contracted a similar disease, caused by the Marburg virus, was successfully treated in Colorado in 2008 after she became ill and had even undergone surgery without transmitting the virus to anyone else.  
 
There are no other suspected Ebola cases in Texas at this time.
 
No therapy or vaccine has yet cleared scientific testing for Ebola although several candidates are currently in clinical trials. To date, the WHO has said that blood transfusions from Ebola survivors  should be the immediate priority treatment. Such blood, hopefully chock-full of antibodies against the virus, could help the newly infected to respond to the disease more quickly. Although the WHO has said the disease kills 70 percent of patients, individuals are more likely to survive when they have access to care that would be offered in the U.S. including electrolyte replacement for lost fluids.
 
More Ebola coverage: Fact or Fiction?: The Ebola Virus Will Go Airborne   Blood Transfusions from Survivors Best Way to Fight Ebola Ebola Doctor Reveals How Infected Americans Were Cured   Patient Zero Believed to Be Sole Source of Ebola Outbreak In-depth report: Ebola: What You Need to Know

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe